Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell-surface integrins and other adhesion receptors are a diverse group of transmembrane proteins that mediate interactions between cells and their environment, including other cells and the extracellular matrix (ECM) (PMID: 11544177). This category includes integrins, cadherins, selectins, and members of the immunoglobulin superfamily (IgSF). These receptors are critical for maintaining tissue architecture, facilitating immune cell trafficking, and transducing mechanical and chemical signals into the cell (PMID: 12415251). In disease, dysregulation of these molecules contributes to cancer metastasis, chronic inflammation, and thrombotic disorders (PMID: 25108302). Therapeutic strategies often involve monoclonal antibodies or small molecules that block ligand binding to prevent pathological adhesion or signaling (PMID: 28855154).
Antagonism of ligand binding to prevent cell-cell or cell-matrix adhesion and inhibit downstream intracellular signaling pathways.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell-surface integrins and other adhesion receptors (CAMs).